510(k) Report

510(k) · Cleared

Recalled · Class II · 2017

Vitros Chemistry Products Hscrp Reagent, Vitros Chemistry Products Calibrator Kit 17, Vitros Chemistry Products FS

K041799510(k) TraditionalCleared Aug 25, 200454-day reviewClass II21 CFR 866.5270Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ortho-Clinical Diagnostics, Inc. · NQD Cardiac C-Reactive Protein, Antigen, Antiserum, And Control

Cleared on Aug 25, 2004 as substantially equivalent to K033908 (Dade Behring, Inc., 2004) and 1 other predicate after a 54-day review. Its family tree reaches back 2 generations to 1999. 2 later devices descend from it. It has been recalled 3 times.

Decided
Aug 25, 2004
Review
54 days
Class
Class II
Product code
NQD
Recalls
3
Predicates
2

Its longest line of descent runs back 2 generations to K991385 (1999). 3 ancestors in all, the oldest K953197 (1995). 2 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1995: 1 other ancestor2015: 1 descendant cleared2004: 1 descendant clearedK991385 · Dade Behring N High Sensitivity CRP Assay · Dade Behring, Inc. · 1999K033908 · N High Sensitivity CRP · Dade Behring, Inc. · 20041995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 2 descendants K033908 · N High Sensitivity CRP · Dade Behring, Inc. · 2004K991385 · Dade Behring N High Sensitivity CRP Assay · Dade Behring, Inc. · 19990
  1. Root · 2 generations backK991385 Dade Behring N High Sensitivity CRP AssayDade Behring, Inc. · 1999
  2. 1 generation backK033908 N High Sensitivity CRPDade Behring, Inc. · 2004
  3. This deviceK041799 Vitros Chemistry Products Hscrp Reagent, Vitros Chemistry Products…Ortho-Clinical Diagnostics, Inc. · 2004
  4. Descendant · cites it directly · 0 of its ownK141689 FastPack High Sensitivity C-Reactive Protein Immunoassay, High…Qualigen, Inc. · 2015
  5. Descendant · cites it directly · 0 of its ownK042838 Vitros Chemistry Products Calibrator Kit 23; Vitros Chemistry…Ortho-Clinical Diagnostics, Inc. · 2004

Most influential descendants

Showing 2 of 2 · See all
  • K141689FastPack High Sensitivity C-Reactive Protein Immunoassay, High Sensitivity C-Reactive…Qualigen, Inc. · 2015 · cites it directly0descendants
  • K042838Vitros Chemistry Products Calibrator Kit 23; Vitros Chemistry Products Palb Performance…Ortho-Clinical Diagnostics, Inc. · 2004 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K991385Dade Behring N High Sensitivity CRP AssayDade Behring, Inc.1999—
−1K033908N High Sensitivity CRPDade Behring, Inc.2004—
0 (this device)K041799Vitros Chemistry Products Hscrp Reagent, Vitros Chemistry Products Calibrator…Ortho-Clinical Diagnostics, Inc.2004—
+1K141689FastPack High Sensitivity C-Reactive Protein Immunoassay, High Sensitivity…Qualigen, Inc.2015—
+1K042838Vitros Chemistry Products Calibrator Kit 23; Vitros Chemistry Products Palb…Ortho-Clinical Diagnostics, Inc.2004—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
201510
FIG. 1 — Lineage of K041799, 1999–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NQD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NQD device

  1. #1 K260026 Tina-quant Cardiac high sensitivity CRP IIIscore 12.3 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K033908N High Sensitivity CRP
Summary page 3
…VITROS Chemistry Products FS Calibrator 1 are substantially equivalent to the N High Sensitivity CRP Assay (Dade Behring, Inc.), which was cleared by FDA (K033908) for IVD use. The relationship between the VITROS hsCRP assay and the predicate device, determined by least square…
Dade Behring, Inc.2004—
*K953197Ektachem Clinical Chemistry Slide C-Reactive Protein (CRP)
Summary page 4
…P Performance Verifiers are substantially equivalent to VITROS Chemistry Products CRP Performance Verifiers (predicate device) which were cleared by the FDA (K953197) for 1VD use. The table below lists the characteristics of the VITROS Chemistry Products hsCRP Performance Verifier…
Johnson & Johnson Clinical Diagnostics, Inc.19953

Also cleared against K033908: 10 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K141689FastPack High Sensitivity C-Reactive Protein Immunoassay, High Sensitivity C-Reactive…Qualigen, Inc.20150
K042838Vitros Chemistry Products Calibrator Kit 23; Vitros Chemistry Products Palb Performance…Ortho-Clinical Diagnostics, Inc.20040

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 5, 2017Class IIIZ-1181-2017Under Investigation by firmThe company received a customer complaint for the inability to calibrate VITROS Chemistry Products dLDL Reagent when using VITROS FS Calibrator 1, Lot 91461 and ADD (DRV 5908). Assay Data Disk (ADD) DRV versions 5904, 5905, 5906, 5907…
May 12, 2014Class IIZ-1804-2014Process change controlCalibrator values assigned for the calibrator kit lots were released using a reference method that was undergoing validation for a new lot of European Reference Material (ERM). The validation process was not complete prior to calibrator…
May 12, 2014Class IIZ-1805-2014Process change controlCalibrator values assigned for the calibrator kit lots were released using a reference method that was undergoing validation for a new lot of European Reference Material (ERM). The validation process was not complete prior to calibrator…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 5 years and passes through 2 companies; a new generation was cleared every 4.2 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K141689 (Qualigen, Inc., 2015) has gone furthest, with 0 descendants of its own.
  • 10 other devices also cite its predicate K033908.

How does its category compare?

All NQD devices

NQD Cardiac C-Reactive Protein, Antigen, Antiserum, And Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NQD

1in 2024

2007: 32008: 12018: 12022: 12024: 12026 (partial year): 1
2007high 3 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NQD

59in 2007

2007: 59 days median
2007high 59 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NQD

2in 2015

2015: 2
2007high 2 (2015) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NQD

2in 2025

2007: 12010: 12011: 52012: 22016: 12017: 12021: 22023: 22024: 12025: 2
2007high 5 (2011) · low 0 (2008)2025

MAUDE reports naming product code NQD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735901
20081—00
20090—00
20100—01
20110—05
20120—02
20130—00
20140—00
20150—20
20160—01
20170—01
20181—00
20190—00
20200—00
20210—02
20221—00
20230—02
20241—01
20250—02
20261—0—

What is it indicated for?

For in vitro diagnostic use only. VITROS Chemistry Products hsCRP Reagent is used to quantitatively measure C-reactive protein (CRP) in human serum and plasma. CRP is used to evaluate the risk of developing coronary heart disease (CHD). The risk of CHD increases with values of CRP that exceed 3 mg/L. For in vitro diagnostic use only. VITROS Chemistry Products Calibrator Kit 17 is used in conjunction with VITROS Chemistry Products FS Calibrator 1 to…

Read the full statement (120 words)

For in vitro diagnostic use only. VITROS Chemistry Products hsCRP Reagent is used to quantitatively measure C-reactive protein (CRP) in human serum and plasma. CRP is used to evaluate the risk of developing coronary heart disease (CHD). The risk of CHD increases with values of CRP that exceed 3 mg/L.

For in vitro diagnostic use only. VITROS Chemistry Products Calibrator Kit 17 is used in conjunction with VITROS Chemistry Products FS Calibrator 1 to calibrate VITROS 5,1 FS Chemistry Systems for the quantitative measurement of C-reactive protein (CRP) using VITROS hsCRP Reagent.

For in vitro diagnostic use only. VITROS Chemistry Products hsCRP Performance Verifiers are assayed controls used to monitor performance of hsCRP Reagent on VITROS 5,1 FS Chemistry Systems.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K041799: Vitros Chemistry Products Hscrp Reagent, Vitros Chemistry Products Calibrator Kit 17, Vitros Chemistry Products FS.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K041799

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026